Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 275,189 | 334,647 | 254,733 | 259,871 | 184,403 |
| Cost of Goods | 130,594 | 92,106 | 119,720 | 136,138 | 159,512 |
| Gross Profit | 144,595 | 242,541 | 135,013 | 123,733 | 24,891 |
| Operating Expenses | 81,635 | 69,096 | 56,980 | 79,268 | 77,207 |
| Operating Income | 63,554 | 173,551 | 78,753 | 44,603 | -51,804 |
| Interest Expense | 21,051 | 20,891 | 19,218 | 17,726 | 13,226 |
| Other Income | 9,513 | 20,209 | -33,151 | 12,723 | -2,500 |
| Pre-tax Income | 52,016 | 172,869 | 26,384 | 39,600 | -67,530 |
| Income Tax | 364 | -30,017 | -738 | 1,852 | 30,901 |
| Net Income Continuous | 51,652 | 202,886 | 27,122 | 37,748 | -98,431 |
| Minority Interests | 51,652 | 1,033 | 342 | 302 | N/A |
| Net Income | $N/A | $201,853 | $26,780 | $37,446 | $-98,431 |
| EPS Basic Total Ops | N/A | N/A | N/A | N/A | -1.37 |
| EPS Basic Continuous Ops | N/A | N/A | N/A | N/A | -1.37 |
| EPS Diluted Total Ops | N/A | N/A | N/A | N/A | -1.37 |
| EPS Diluted Continuous Ops | N/A | N/A | N/A | N/A | -1.37 |
| EBITDA(a) | $79,475 | $187,083 | $92,143 | $42,451 | $-26,053 |